NCT00004759View on ClinicalTrials.gov

Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

497

Participants

Timeline

Start Date

December 31, 1991

Primary Completion Date

August 31, 2007

Conditions
Spinal Cord Injury
Interventions
DRUG

methylprednisolone

DRUG

tirilazad

All Listed Sponsors
collaborator

Yale University

OTHER

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00004759 - Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury | Biotech Hunter | Biotech Hunter